Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HILDRUM FYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.5% 1.0% 1.6% 1.2% 1.3% 0.9% 9.9% 9.9%   Credit score (0-100)   78 88 75 82 80 87 25 25   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   9.2 259.5 7.2 97.0 54.3 249.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,025 1,730 943 1,305 1,563 1,683 0.0 0.0   EBITDA   511 1,326 203 419 627 746 0.0 0.0   EBIT   477 1,306 183 408 616 735 0.0 0.0   Pre-tax profit (PTP)   449.9 1,313.3 -55.8 306.3 316.6 656.8 0.0 0.0   Net earnings   338.7 1,032.5 -100.8 238.9 201.8 508.4 0.0 0.0   Pre-tax profit without non-rec. items   450 1,313 -55.8 306 317 657 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,165 1,873 6,769 6,768 6,758 6,747 0.0 0.0   Shareholders equity total   1,787 2,670 2,355 2,522 2,574 2,882 1,671 1,671   Interest-bearing liabilities   1,632 1,056 5,808 5,681 5,794 5,405 0.0 0.0   Balance sheet total (assets)   3,959 4,198 8,805 8,950 9,226 8,728 1,671 1,671   Net Debt   1,632 -401 4,641 4,639 4,391 5,180 -1,671 -1,671     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,025 1,730 943 1,305 1,563 1,683 0.0 0.0   Gross profit growth   -18.5% 68.8% -45.5% 38.4% 19.8% 7.7% -100.0% 0.0%   Employees   1 1 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,959 4,198 8,805 8,950 9,226 8,728 1,671 1,671   Balance sheet change%   0.2% 6.0% 109.8% 1.7% 3.1% -5.4% -80.9% 0.0%   Added value   510.5 1,326.4 203.3 419.0 627.0 746.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -48 -1,312 4,876 -11 -21 -21 -6,747 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   46.5% 75.5% 19.4% 31.3% 39.4% 43.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   13.4% 32.8% 3.7% 5.1% 7.3% 8.8% 0.0% 0.0%   ROI %   14.2% 38.9% 4.1% 5.5% 8.0% 9.5% 0.0% 0.0%   ROE %   19.4% 46.3% -4.0% 9.8% 7.9% 18.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   45.8% 64.1% 26.7% 28.2% 27.9% 33.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   319.7% -30.2% 2,283.0% 1,107.0% 700.4% 694.3% 0.0% 0.0%   Gearing %   91.3% 39.6% 246.6% 225.2% 225.1% 187.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.9% 1.7% 8.6% 2.6% 6.0% 2.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 3.4 2.0 2.0 1.7 3.8 0.0 0.0   Current Ratio   0.7 3.2 2.0 2.0 1.7 3.8 0.0 0.0   Cash and cash equivalent   0.0 1,457.2 1,166.8 1,042.1 1,402.5 225.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -256.2 1,507.1 533.6 570.7 724.5 1,127.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   511 1,326 102 210 313 373 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   511 1,326 102 210 313 373 0 0   EBIT / employee   477 1,306 92 204 308 368 0 0   Net earnings / employee   339 1,032 -50 119 101 254 0 0